These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 20655381

  • 1. Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin.
    Kono S, Yoshida K, Tomosugi N, Terada T, Hamaya Y, Kanaoka S, Miyajima H.
    Biochim Biophys Acta; 2010 Nov; 1802(11):968-75. PubMed ID: 20655381
    [Abstract] [Full Text] [Related]

  • 2. The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.
    Wallace DF, McDonald CJ, Ostini L, Iser D, Tuckfield A, Subramaniam VN.
    Am J Hematol; 2017 Oct; 92(10):1052-1061. PubMed ID: 28681497
    [Abstract] [Full Text] [Related]

  • 3. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin.
    De Domenico I, Ward DM, di Patti MC, Jeong SY, David S, Musci G, Kaplan J.
    EMBO J; 2007 Jun 20; 26(12):2823-31. PubMed ID: 17541408
    [Abstract] [Full Text] [Related]

  • 4. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
    Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J.
    Science; 2004 Dec 17; 306(5704):2090-3. PubMed ID: 15514116
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.
    De Domenico I, Lo E, Ward DM, Kaplan J.
    Proc Natl Acad Sci U S A; 2009 Mar 10; 106(10):3800-5. PubMed ID: 19234114
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aceruloplasminemia.
    Kono S.
    Curr Drug Targets; 2012 Aug 10; 13(9):1190-9. PubMed ID: 22515740
    [Abstract] [Full Text] [Related]

  • 14. Dominant mutants of ceruloplasmin impair the copper loading machinery in aceruloplasminemia.
    di Patti MC, Maio N, Rizzo G, De Francesco G, Persichini T, Colasanti M, Polticelli F, Musci G.
    J Biol Chem; 2009 Feb 13; 284(7):4545-54. PubMed ID: 19095659
    [Abstract] [Full Text] [Related]

  • 15. High-throughput screening of small molecules identifies hepcidin antagonists.
    Fung E, Sugianto P, Hsu J, Damoiseaux R, Ganz T, Nemeth E.
    Mol Pharmacol; 2013 Mar 13; 83(3):681-90. PubMed ID: 23292796
    [Abstract] [Full Text] [Related]

  • 16. Iron-regulatory gene expression during liver regeneration.
    Mollbrink A, Holmström P, Sjöström M, Hultcrantz R, Eriksson LC, Stål P.
    Scand J Gastroenterol; 2012 May 13; 47(5):591-600. PubMed ID: 22364558
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepcidin-ferroportin axis in health and disease.
    Ginzburg YZ.
    Vitam Horm; 2019 May 13; 110():17-45. PubMed ID: 30798811
    [Abstract] [Full Text] [Related]

  • 19. Immune cells and hepatocytes express glycosylphosphatidylinositol-anchored ceruloplasmin at their cell surface.
    Marques L, Auriac A, Willemetz A, Banha J, Silva B, Canonne-Hergaux F, Costa L.
    Blood Cells Mol Dis; 2012 Feb 15; 48(2):110-20. PubMed ID: 22178061
    [Abstract] [Full Text] [Related]

  • 20. Efficient oxidative folding and site-specific labeling of human hepcidin to study its interaction with receptor ferroportin.
    Luo X, Jiang Q, Song G, Liu YL, Xu ZG, Guo ZY.
    FEBS J; 2012 Sep 15; 279(17):3166-75. PubMed ID: 22776295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.